Open AccessGSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients
Author(s) -
Guochun Zhang,
Xin Qian,
Chen Ren,
Lingzhu Wen,
Haitong Lyu,
Ning Liao
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.04.03
Subject(s) - taxane , medicine , oncology , breast cancer , chemotherapy , estrogen receptor , estrogen , cancer